Portolan Capital Management’s Candel Therapeutics CADL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$8.21M	Buy	1,621,728 +740,544	+84%	+$3.75M	0.51%	63
2025 Q1	$4.98M	Buy	881,184 +127,439	+17%	+$720K	0.38%	73
2024 Q4	$6.54M	Buy	+753,745	New	+$6.54M	0.44%	74